Login / Signup

Nasal Inflammation and Ulceration Secondary to Repeated Use of an Intranasal Delivery Device in Rabbits.

Yuval RamotDalia Shabashov StoneRuth GoldschmidtAbraham Nyska
Published in: Toxicologic pathology (2020)
Intranasal administration of drugs is gaining popularity in medicine, and several animal models have been used to test the safety and efficacy of this delivery route. Nevertheless, the nasal anatomy of animals is different from humans, which can lead to pathological changes that stem from the delivery device and not the drug itself. Here, we report on nasal inflammation and ulceration in rabbits, secondary to the repeated trauma caused by the intranasal device. Similar changes were noted in the animals treated with the vehicle and with the tested drug, and therefore, these changes were not attributed to the drug itself. In some animals, superficial ulcer and stromal inflammation were noted in the eyes, secondary to nasal duct obstruction from the nasal inflammation. These observations emphasize the importance of proper interpretation of histopathological changes, attributed to trauma-induced pathological changes related to the handling of the animal and not to the tested product, which is the drug itself and the device that is optimized for clinical (human) use.
Keyphrases
  • oxidative stress
  • chronic rhinosinusitis
  • drug induced
  • endothelial cells
  • adverse drug
  • diabetic rats
  • bone marrow
  • high glucose
  • emergency department
  • induced pluripotent stem cells